|

Obecabtagene autoleucel Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Obe-cel

Pipeline

Phase 2: 2

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1
  • M.D. Anderson Cancer Center1

Indications

  • Cancer2
  • Acute Lymphocytic Leukemia (ALL)1
  • Acute Lymphoblastic Leukemia1

Basking Ridge, New Jersey1 trial

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)

Phase 2

Houston, Texas1 trial

Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)

The University of Texas M. D. Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.